Acute kidney injury in patients with chronic heart failure
https://doi.org/10.21886/2712-8156-2021-2-3-6-17
Abstract
The problem of chronic heart failure (CHF) and especially CHF with reduced ejection fraction is one of the most significant for modern healthcare systems. This is due to the high mortality rate, reduced quality of life, frequent hospitalizations and marked comorbidity of patients with this pathology. Involvement of the kidneys in the pathological process is one of the most common comorbid conditions in cardiovascular disease. There are a large number of pathogenetic mechanisms of mutually negative impact of heart failure and renal dysfunction, reflected in the concept of «Cardiorenal syndrome». Moreover, drug therapy of CHF can be one of the causes of kidney damage. Episodes of acute circulatory decompensation as well as a new coronavirus infection (COVID-19) are particularly threatening conditions. The aim of this review is to consolidate the international literature on the problem of acute kidney injury in patients with CHF.
About the Authors
A. G. Arutyunov
Pirogov Russian National Research Medical University;
“Eurasian Association of Therapists”
Russian Federation
Russian Federation
Alexander G. Arutyunov, Dr. Sci. (Med.), Professor of Department of Internal Medicine Propaedeutics of the Pediatric Faculty;
General secretary
Moscow
R. A. Bashkinov
“Eurasian Association of Therapists”
Russian Federation
Russian Federation
Roman A. Bashkinov, Medical advisor
Moscow
T. I. Batluk
Pirogov Russian National Research Medical University;
“Eurasian Association of Therapists”
Russian Federation
Russian Federation
Tatiana I. Batluk, Cand. Sci. (Med.), Assistant of Department of Internal Medicine Propaedeutics of the Pediatric Faculty;
Medical advisor
Moscow
E. S. Melnikov
“Eurasian Association of Therapists”
Russian Federation
Russian Federation
Evgeny S. Melnikov, Medical advisor
Moscow
A. N. Ermilova
“Eurasian Association of Therapists”
Russian Federation
Russian Federation
Anastasia N. Ermilova, Medical advisor
Moscow
References
1. Ассоциация нефрологов, Научное общество нефрологов России, Ассоциация анестезиологов-реаниматологов России, Национальное общество специалистов в области гемафереза и экстракорпоральной гемокорреции. Клинические рекомендации «Острое повреждение почек (ОПП)». 2020.
2. Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group. KDIGO Clinical Practice Guideline for Acute Kidney Injury. Kidney inter., Suppl. 2012;2:1–138. Doi: 10.1038/kisup.2012.6
3. Chertow G.M., Burdick E., Honour M., Bonventre J.V., Bates D.W. Acute kidney injury, mortality, length of stay, and costs in hospitalized patients. J Am Soc Nephrol. 2005;16(11):3365-3370. Doi: 10.1681/ASN.2004090740
4. Uchino S., Bellomo R., Goldsmith D., Bates S., Ronco C. An assessment of the RIFLE criteria for acute renal failure in hospitalized patients. Crit Care Med. 2006;34(7):1913-1917. Doi: 10.1097/01.CCM.0000224227.70642.4F
5. Mandelbaum T., Scott D.J., Lee J., Mark R.G., Malhotra A., Waikar S.S., et al. Outcome of critically ill patients with acute kidney injury using the Acute Kidney Injury Network criteria. Crit Care Med. 2011;39(12):2659-2664. Doi: 10.1097/CCM.0b013e3182281f1b
6. Bucaloiu I.D., Kirchner H.L., Norfolk E.R., Hartle J.E. 2nd, Perkins R.M. Increased risk of death and de novo chronic kidney disease following reversible acute kidney injury. Kidney Int. 2012;81(5):477-485. Doi: 10.1038/ki.2011.405
7. Lafrance J.P., Djurdjev O., Levin A. Incidence and outcomes of acute kidney injury in a referred chronic kidney disease cohort. Nephrol Dial Transplant. 2010;25(7):2203-2209. Doi: 10.1093/ndt/gfq011
8. Ronco C., Bellomo R., Kellum J.A. Acute kidney injury. Lancet. 2019;394(10212):1949-1964. Doi: 10.1016/S0140-6736-(19)32563-2
9. Wang H.E., Muntner P., Chertow G.M., Warnock D.G. Acute kidney injury and mortality in hospitalized patients. Am J Nephrol. 2012;35(4):349-355. Doi: 10.1159/000337487
10. Rosner M.H., Okusa M.D. Acute kidney injury associated with cardiac surgery. Clin J Am Soc Nephrol. 2006;1(1):19-32. Doi: 10.2215/CJN.00240605
11. Chertow G.M., Levy E.M., Hammermeister K.E., Grover F., Daley J. Independent association between acute renal failure and mortality following cardiac surgery. Am J Med. 1998;104(4):343-348. Doi: 10.1016/s0002-9343(98)00058-8
12. Damman K., Masson S., Lucci D., Gorini M., Urso R., Maggioni A.P., et al. Progression of Renal Impairment and Chronic Kidney Disease in Chronic Heart Failure: An Analysis From GISSI-HF. J Card Fail. 2017;23(1):2-9. Doi: 10.1016/j.cardfail.2016.09.006
13. Zeng X., McMahon G.M., Brunelli S.M., Bates D.W., Waikar S.S. Incidence, outcomes, and comparisons across definitions of AKI in hospitalized individuals. Clin J Am Soc Nephrol. 2014;9(1):12-20. Doi: 10.2215/CJN.02730313
14. Ronco C., Haapio M., House A.A., Anavekar N., Bellomo R. Cardiorenal andomiz. J Am Coll Cardiol. 2008;52(19):1527-1539. Doi: 10.1016/j.jacc.2008.07.051
15. Pokhrel N., Maharjan N., Dhakal B., Arora R.R. Cardiorenal syndrome: A literature review. Exp Clin Cardiol. 2008;13(4):165-170. PMID: 19343160; PMCID: PMC2663478
16. Резник Е.В., Никитин И.Г. Кардиоренальный синдром у больных с сердечной недостаточностью как этап кардиоренального континуума (часть 1): определение, классификация, патогенез, диагностика, эпидемиология (обзор литературы). Архивъ внутренней медицины. 2019;9(1):5-22. Doi: 10.20514/2226-6704-2019-9-1-5-22
17. Nohria A., Hasselblad V., Stebbins A., Pauly D.F., Fonarow G.C., Shah M., et al. Cardiorenal interactions: insights from the ESCAPE trial. J Am Coll Cardiol. 2008;51(13):1268-1274. Doi: 10.1016/j.jacc.2007.08.072
18. Heywood J.T., Fonarow G.C., Costanzo M.R., Mathur V.S., Wigneswaran J.R., Wynne J., et al. High prevalence of renal dysfunction and its impact on outcome in 118,465 patients hospitalized with acute decompensated heart failure: a report from the ADHERE database. Card Fail. 2007;13(6):422-430. Doi: 10.1016/j.cardfail.2007.03.011
19. Tonelli M., Wiebe N., Culleton B., House A., Rabbat C., Fok M., et al. Chronic kidney disease and mortality risk: a systematic review. J Am Soc Nephrol. 2006;17(7):2034-2047. Doi: 10.1681/ASN.2005101085
20. Forman D.E., Butler J., Wang Y., Abraham W.T., O’Connor C.M., Gottlieb S.S., et al. Incidence, predictors at admission, and impact of worsening renal function among patients hospitalized with heart failure. J Am Coll Cardiol. 2004;43(1):61-67. Doi: 10.1016/j.jacc.2003.07.031
21. Gottlieb S.S., Abraham W., Butler J., Forman D.E., Loh E., Massie B.M., et al. The prognostic importance of different definitions of worsening renal function in congestive heart failure. J Card Fail. 2002;8(3):136-141. Doi: 10.1054/jcaf.2002.125289
22. Goldberg A., Hammerman H., Petcherski S., Zdorovyak A., Yalonetsky S., Kapeliovich M., et al. Inhospital and 1-year mortality of patients who develop worsening renal function following acute ST-elevation myocardial infarction. Am Heart J. 2005;150(2):330-337. Doi: 10.1016/j.ahj.2004.09.055
23. Parikh C.R., Coca S.G., Wang Y., Masoudi F.A., Krumholz H.M. Long-term prognosis of acute kidney injury after acute myocardial infarction. Arch Intern Med. 2008;168(9):987-995. Doi: 10.1001/archinte.168.9.987
24. Jose P., Skali H., Anavekar N., Tomson C., Krumholz H.M., Rouleau J.L., et al. Increase in creatinine and cardiovascular risk in patients with systolic dysfunction after myocardial infarction. J Am Soc Nephrol. 2006;17(10):2886-2891. Doi: 10.1681/ASN.2006010063
25. Krumholz H.M., Chen Y.T., Vaccarino V., Wang Y., Radford M.J., Bradford W.D., et al. Correlates and impact on outcomes of worsening renal function in patients > or =65 years of age with heart failure. Am J Cardiol. 2000;85(9):1110-1113. Doi: 10.1016/s0002-9149(00)00705-0
26. Metra M., Nodari S., Parrinello G., Bordonali T., Bugatti S., Danesi R., et al. Worsening renal function in patients andomizedd for acute heart failure: clinical implications and prognostic significance. Eur J Heart Fail. 2008;10(2):188-195. Doi: 10.1016/j.ejheart.2008.01.011
27. Cowie M.R., Komajda M., Murray-Thomas T., Underwood J., Ticho B. Prevalence and impact of worsening renal function in patients hospitalized with decompensated heart failure: results of the prospective outcomes study in heart failure (POSH). Eur Heart J. 2006;27(10):1216-1222. Doi: 10.1093/eurheartj/ehi859
28. Smith G.L., Vaccarino V., Kosiborod M., Lichtman J.H., Cheng S., Watnick S.G., et al. Worsening renal function: what is a clinically meaningful change in creatinine during hospitalization with heart failure?. J Card Fail. 2003;9(1):13-25. Doi: 10.1054/jcaf.2003.3
29. Latchamsetty R., Fang J., Kline-Rogers E., Mukherjee D., Otten R.F., LaBounty T.M., et al. Prognostic value of transient and sustained increase in in-hospital creatinine on outcomes of patients admitted with acute coronary syndrome. Am J Cardiol. 2007;99(7):939-942. Doi: 10.1016/j.amjcard.2006.10.058
30. Newsome B.B., Warnock D.G., McClellan W.M., Herzog C.A., Kiefe C.I., Eggers P.W., et al. Long-term risk of mortality and end-stage renal disease among the elderly after small increases in serum creatinine level during hospitalization for acute myocardial infarction. Arch Intern Med. 2008;168(6):609-616. Doi: 10.1001/archinte.168.6.609
31. Logeart D., Tabet J.Y., Hittinger L., Thabut G., Jourdain P., Maison P., et al. Transient worsening of renal function during hospitalization for acute heart failure alters outcome. Int J Cardiol. 2008;127(2):228-232. Doi: 10.1016/j.ijcard.2007.06.007
32. Fonarow G.C., Adams K.F. Jr., Abraham W.T., Yancy C.W., Boscardin W.J.; ADHERE Scientific Advisory Committee, Study Group, and Investigators. Risk stratification for in-hospital mortality in acutely decompensated heart failure: classification and regression tree analysis. JAMA. 2005;293(5):572-580. Doi: 10.1001/jama.293.5.572
33. Lee D.S., Austin P.C., Rouleau J.L., Liu P.P., Naimark D., Tu J.V. Predicting mortality among patients hospitalized for heart failure: derivation and validation of a clinical model. JAMA. 2003;290(19):2581-2587. Doi: 10.1001/jama.290.19.2581
34. De Luca L., Fonarow G.C., Adams K.F. Jr., Mebazaa A., Tavazzi L., Swedberg K., et al. Acute heart failure syndromes: clinical scenarios and pathophysiologic targets for therapy. Heart Fail Rev. 2007;12(2):97-104. Doi: 10.1007/s10741-007-9011-8
35. Gheorghiade M., Abraham W.T., Albert N.M., Greenberg B.H., O’Connor C.M., She L., et al.; OPTIMIZE-HF Investigators and Coordinators. Systolic blood pressure at admission, clinical characteristics, and outcomes in patients hospitalized with acute heart failure. JAMA. 2006;296(18):2217-2226. Doi: 10.1001/jama.296.18.2217
36. Hillege H.L., Nitsch D., Pfeffer M.A., Swedberg K., McMurray J.J., Yusuf S., et al. Renal function as a predictor of outcome in a broad spectrum of patients with heart failure. Circulation. 2006;113(5):671-678. Doi: 10.1161/CIRCULATIONAHA.105.580506
37. Holgado J.L., Lopez C., Fernandez A., Sauri I., Uso R., Trillo J.L., et al. Acute kidney injury in heart failure: a population study. ESC Heart Fail. 2020;7(2):415-422. Doi: 10.1002/ehf2.12595
38. Hillege H.L., Girbes A.R., de Kam P.J., Boomsma F., de Zeeuw D., Charlesworth A., et al. Renal function, neurohormonal activation, and survival in patients with chronic heart failure. Circulation. 2000;102(2):203-210. Doi: 10.1161/01.cir.102.2.203
39. Mullens W., Abrahams Z., Skouri H.N., Francis G.S., Taylor D.O., Starling R.C., et al. Elevated intra-abdominal pressure in acute decompensated heart failure: a potential contributor to worsening renal function?. J Am Coll Cardiol. 2008;51(3):300-306. Doi: 10.1016/j.jacc.2007.09.043
40. Mullens W., Abrahams Z., Francis G.S., Taylor D.O., Starling R.C., Tang W.H. Prompt reduction in intra-abdominal pressure following large-volume mechanical fluid removal improves renal insufficiency in refractory decompensated heart failure. J Card Fail. 2008;14(6):508-514. Doi: 10.1016/j.cardfail.2008.02.010
41. Tang W.H., Mullens W. Cardiorenal syndrome in decompensated heart failure. Heart. 2010;96(4):255-260. Doi: 10.1136/hrt.2009.166256
42. Mullens W., Nijst P. Cardiac Output and Renal Dysfunction: Definitely More Than Impaired Flow. J Am Coll Cardiol. 2016;67(19):2209-2212. Doi: 10.1016/j.jacc.2016.03.537
43. Hanberg J.S., Sury K., Wilson F.P., Brisco M.A., Ahmad T., Ter Maaten J.M.,, et al. J Am Coll Cardiol. 2016;67(19):2199-2208. Doi: 10.1016/j.jacc.2016.02.058
44. Testani J.M., Chen J., McCauley B.D., Kimmel S.E., Shannon R.P. Potential effects of aggressive decongestion during the treatment of decompensated heart failure on renal function and survival. Circulation. 2010;122(3):265-272. Doi: 10.1161/CIRCULATIONAHA.109.933275
45. Verbrugge F.H., Grieten L., Mullens W. Management of the cardiorenal syndrome in decompensated heart failure. Cardiorenal Med. 2014;4(3-4):176-188. Doi: 10.1159/000366168
46. Verbrugge F.H., Dupont M., Steels P., Grieten L., Malbrain M., Tang W.H., et al. Abdominal contributions to cardiorenal dysfunction in congestive heart failure. Abdominal contributions to cardiorenal dysfunction in congestive heart failure. J Am Coll Cardiol. 2013;62(6):485-495. Doi: 10.1016/j.jacc.2013.04.070
47. Dupont M., Mullens W., Finucan M., Taylor D.O., Starling R.C., Tang W.H. Determinants of dynamic changes in serum creatinine in acute decompensated heart failure: the importance of blood pressure reduction during treatment. Eur J Heart Fail. 2013;15(4):433-440. Doi: 10.1093/eurjhf/hfs209
48. Damman K., Navis G., Voors A.A., Asselbergs F.W., Smilde T.D., Cleland J.G., et al. Worsening renal function and prognosis in heart failure: systematic review and meta-analysis. J Card Fail. 2007;13(8):599-608. Doi: 10.1016/j.cardfail.2007.04.008
49. Cody R.J., Ljungman S., Covit A.B., Kubo S.H., Sealey J.E., Pondolfino K., et al. Regulation of glomerular filtration rate in chronic congestive heart failure patients. Kidney Int. 1988;34(3):361-367. Doi: 10.1038/ki.1988.189
50. Cody R.J., Torre S., Clark M., Pondolfino K. Age-related hemodynamic, renal, and hormonal differences among patients with congestive heart failure. Arch Intern Med. 1989;149(5):1023-1028. PMID: 2655542.
51. Rangaswami J., Bhalla V., Blair J.E.A., Chang T.I., Costa S., Lentine K.L., et al. Cardiorenal Syndrome: Classification, Pathophysiology, Diagnosis, and Treatment Strategies: A Scientific Statement From the American Heart Association. Circulation. 2019;139(16):e840-e878. Doi: 10.1161/CIR.000000000000066452. Mullens W., Verbrugge F.H., Nijst P., Tang W.H.W. Renal sodium
52. avidity in heart failure: from pathophysiology to treatment strategies. Eur Heart J. 2017;38(24):1872-1882. Doi: 10.1093/eurheartj/ehx035
53. GOTTSCHALK C.W. Micropuncture studies of tubular function in the mammalian kidney. Folia Med Neerl. 1962;5:11-30. PMID: 13900773.
54. Park F., Mattson D.L., Skelton M.M., Cowley A.W.Jr. Localization of the vasopressin V1a and V2 receptors within the renal cortical and medullary circulation. Am J Physiol. 1997;273(1 Pt 2):R243-R251. Doi: 10.1152/ajpregu.1997.273.1.R243
55. Star R.A., Nonoguchi H., Balaban R., Knepper M.A. Calcium and cyclic adenosine monophosphate as second messengers for vasopressin in the rat inner medullary collecting duct. J Clin Invest. 1988;81(6):1879-1888. Doi: 10.1172/JCI113534
56. Schrier R.W. Aldosterone ‘escape’ vs ‘breakthrough’. Nat Rev Nephrol. 2010;6(2):61. Doi: 10.1038/nrneph.2009.228
57. Damman K., van Deursen V.M., Navis G., Voors A.A., van Veldhuisen D.J., Hillege H.L. Increased central venous pressure is associated with impaired renal function and mortality in a broad spectrum of patients with cardiovascular disease. J Am Coll Cardiol. 2009;53(7):582-588. Doi: 10.1016/j.jacc.2008.08.080
58. Mullens W., Abrahams Z., Francis G.S., Sokos G., Taylor D.O., Starling R.C., et al. Importance of venous congestion for worsening of renal function in advanced decompensated heart failure. J Am Coll Cardiol. 2009;53(7):589-596. Doi: 10.1016/j.jacc.2008.05.068
59. Verhaert D., Mullens W., Borowski A., Popović Z.B., Curtin R.J., Thomas J.D., et al. Right ventricular response to intensive medical therapy in advanced decompensated heart failure. Circ Heart Fail. 2010;3(3):340-346. Doi: 10.1161/CIRCHEARTFAILURE.109.900134
60. Burnett J.C. Jr., Haas J.A., Knox F.G. Segmental analysis of sodium reabsorption during renal vein constriction. Am J Physiol. 1982;243(1):F19-F22. Doi: 10.1152/ajprenal.1982.243.1.F19
61. Wathen R.L., Selkurt E.E. Intrarenal regulatory factors of salt excretion during renal venous pressure elevation. Am J Physiol. 1969;216(6):1517-1524. Doi: 10.1152/ajplegacy.1969.216.6.1517
62. Maxwell M.H., Breed E.S., Schwartz I.L. Renal venous pressure in chronic congestive heart failure. J Clin Invest. 1950;29(3):342-348. Doi: 10.1172/JCI102263
63. Damman K., Navis G., Smilde T.D., Voors A.A., van der Bij W., van Veldhuisen D.J., et al. Decreased cardiac output, venous congestion and the association with renal impairment in patients with cardiac dysfunction. Eur J Heart Fail. 2007;9(9):872-878. Doi: 10.1016/j.ejheart.2007.05.010
64. Mullens W., Damman K., Testani J.M., Martens P., Mueller C., Lassus J., et al. Evaluation of kidney function throughout the heart failure trajectory – a position statement from the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail. 2020;22(4):584-603. Doi: 10.1002/ejhf.1697
65. Damman K., Valente M.A., Voors A.A., O’Connor C.M., van Veldhuisen D.J., Hillege H.L. Renal impairment, worsening renal function, and outcome in patients with heart failure: an updated meta-analysis. Eur Heart J. 2014;35(7):455-469. Doi: 10.1093/eurheartj/eht386
66. Kula A.J., Hanberg J.S., Wilson F.P., Brisco M.A., Bellumkonda L., Jacoby D., et al. Influence of Titration of Neurohormonal Antagonists and Blood Pressure Reduction on Renal Function and Decongestion in Decompensated Heart Failure. Circ Heart Fail. 2016;9(1):e002333. Doi: 10.1161/CIRCHEARTFAILURE.115.002333
67. Verbrugge F.H., Duchenne J., Bertrand P.B., Dupont M., Tang W.H., Mullens W. Uptitration of renin-angiotensin system blocker and beta-blocker therapy in patients hospitalized for heart failure with reduced versus preserved left ventricular ejection fractions. Am J Cardiol. 2013;112(12):1913-1920. Doi: 10.1016/j.amjcard.2013.08.013
68. Packer M., Lee W.H., Kessler .PD. Preservation of glomerular filtration rate in human heart failure by activation of the renin-angiotensin system. Circulation. 1986;74(4):766-774. Doi: 10.1161/01.cir.74.4.766
69. CONSENSUS Trial Study Group. Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). N Engl J Med. 1987;316(23):1429-1435. Doi: 10.1056/NEJM198706043162301
70. Ljungman S., Kjekshus J., Swedberg K. Renal function in severe congestive heart failure during treatment with enalapril (the Cooperative North Scandinavian Enalapril Survival Study [CONSENSUS] Trial). Am J Cardiol. 1992;70(4):479-487. Doi: 10.1016/0002-9149(92)91194-9
71. Williams B., Mancia G., Spiering W., Agabiti Rosei E., Azizi M., Burnier M., et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension: The Task Force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension [published correction appears in J Hypertens. 2019 Jan;37(1):226]. J Hypertens. 2018;36(10):1953-2041. Doi: 10.1097/HJH.0000000000001940
72. Brunner-La Rocca H.P., Knackstedt C., Eurlings L., Rolny V., Krause F., Pfisterer M.E., et al. Impact of worsening renal function related to medication in heart failure. Eur J Heart Fail. 2015;17(2):159-168. Doi: 10.1002/ejhf.210
73. Арутюнов А.Г., Драгунов Д.О., Арутюнов Г.П., Рылова А.К., Соколова А.В. Влияние на прогноз комбинированной мочегонной терапии у пациентов, страдающих циррозом печени, ХБП и пневмонией на фоне декомпенсации кровообращения. Журнал Сердечная Недостаточность. 2015;16(1):11–21. eLIBRARY ID: 25277006
74. Арутюнов А.Г., Драгунов Д.О., Арутюнов Г.П., Рылова А.К., Соколова А.В. Влияние лекарственных форм петлевого диуретика с различной скоростью высвобождения на ранний и отсроченный прогноз у пациентов с декомпенсацией кровообращения. Кардиология. 2015;54(9):24-32. Doi: 10.18565/cardio.2014.9.24-32.
75. Firth J.D., Raine A.E., Ledingham J.G. Raised venous pressure: a direct cause of renal sodium retention in oedema?. Lancet. 1988;1(8593):1033-1035. Doi: 10.1016/s0140-6736-(88)91851-x
76. Wehling M. Morbus diureticus in the elderly: epidemic overuse of a widely applied group of drugs. J Am Med Dir Assoc. 2013;14(6):437-442. Doi: 10.1016/j.jamda.2013.02.002
77. Ahmed A., Husain A., Love T.E., Gambassi G., Dell’Italia L.J., Francis G.S., et al. Heart failure, chronic diuretic use, and increase in mortality and hospitalization: an observational study using propensity score methods. Eur Heart J. 2006;27(12):1431-1439. Doi: 10.1093/eurheartj/ehi890
78. Ali S.S., Olinger C.C., Sobotka P.A., Dahle T.G., Bunte M.C., Blake D., et al. Loop diuretics can cause clinical natriuretic failure: a prescription for volume expansion. Congest Heart Fail. 2009;15(1):1-4. Doi: 10.1111/j.1751-7133.2008.00037.x
79. Ljungman S., Laragh J.H., Cody R.J. Role of the kidney in congestive heart failure. Relationship of cardiac index to kidney function. Drugs. 1990;39 Suppl 4:10-24. Doi: 10.2165/00003495-199000394-00004
80. Testani J.M., Chen J., McCauley B.D., Kimmel S.E., Shannon R.P. Potential effects of aggressive decongestion during the treatment of decompensated heart failure on renal function and survival. Circulation. 2010;122(3):265-272. Doi: 10.1161/CIRCULATIONAHA.109.933275
81. Wanner C., Inzucchi S.E., Lachin J.M., Fitchett D., von Eynatten M., Mattheus M. et al. Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes. N Engl J Med. 2016;375(4):323-334. Doi:10.1056/NEJMoa1515920
82. Perkovic V., de Zeeuw D., Mahaffey K.W., Fulcher G., Erondu N., Shaw W. et al. Canagliflozin and renal outcomes in type 2 diabetes: results from the CANVAS Program andomized clinical trials. Lancet Diabetes Endocrinol. 2018;6(9):691-704. Doi: 10.1016/S2213-8587(18)30141-4
83. Mosenzon O., Wiviott S.D., Cahn A., Rozenberg A., Yanuv I., Goodrich E.L., et al. Effects of dapagliflozin on development and progression of kidney disease in patients with type 2 diabetes: an analysis from the DECLARE-TIMI 58 randomised trial [published correction appears in Lancet Diabetes Endocrinol. 2019 Aug;7(8):e20]. Lancet Diabetes Endocrinol. 2019;7(8):606-617. Doi: 10.1016/S2213-8587(19)30180-9
84. Damman K., Gori M., Claggett B., Jhund P.S., Senni M., Lefkowitz M.P., et al. Renal Effects and Associated Outcomes During Angiotensin-Neprilysin Inhibition in Heart Failure. JACC Heart Fail. 2018;6(6):489-498. Doi: 10.1016/j.jchf.2018.02.004
85. Арутюнов А.Г., Рылова А.К., Арутюнов Г.П. Пневмония у госпитализированных пациентов с декомпенсацией кровообращения (Регистр Павловской больницы). Журнал сердечная недостаточность. 2014;15(3):146-159. eLIBRARY ID: 25276966
86. Арутюнов А.Г., Драгунов Д.О., Арутюнов Г.П., Соколова А.В., Рылова А.К. Влияние основных факторов риска у пациентов на прогноз при декомпенсации сердечной недостаточности. Кардиология. 2014;54(12):37-43. Doi: 10.18565/cardio.2014.12.37-43.
87. Арутюнов А.Г., Драгунов Д.О., Арутюнов Г.П., Рылова А.К., Пашкевич Д.Д., Витер К.В., и др. Первое открытое исследование синдрома острой декомпенсации сердечной недостаточности и сопутствующих заболеваний в Российской Федерации. Независимый регистр ОРАКУЛРФ. Кардиология. 2015;55(5):12-21. doi: 10.18565/cardio.2015.5.12-21
88. Арутюнов Г.П., Тарловская Е.И., Арутюнов А.Г., Беленков Ю.Н., Конради А.О., Лопатин Ю.М., и др. Международный регистр “Анализ динамики Коморбидных заболеваний у пациенТов, перенесшИх инфицироВание SARS-CoV-2” (AКТИВ) и регистр “Анализ госпитализаций Коморбидных пациенТов ИнфицироВанных в период второй волны SARS-CoV-2” (AКТИВ 2). Российский кардиологический журнал. 2021;26(3):4358. doi: 10.15829/1560-4071-2021-4358.
89. Арутюнов Г.П., Тарловская Е.И., Арутюнов А.Г., Беленков Ю.Н., Конради А.О., Лопатин Ю.М., и др. Международный регистр “Анализ динамики Коморбидных заболеваний у пациенТов, перенесших инфицирование SARS-CoV-2” (АКТИВ SARS-CoV-2): анализ предикторов неблагоприятных исходов острой стадии новой коронавирусной инфекции. Российский кардиологический журнал. 2021;26(4):4470. doi: 10.15829/1560-4071-2021-4470
Supplementary files
Review
For citations:
Arutyunov A.G., Bashkinov R.A., Batluk T.I., Melnikov E.S., Ermilova A.N. Acute kidney injury in patients with chronic heart failure. South Russian Journal of Therapeutic Practice. 2021;2(3):6-17. (In Russ.) https://doi.org/10.21886/2712-8156-2021-2-3-6-17
Views:
5314
Email this article 